http://www.ncbi.nlm.nih.gov/pubmed/23544932

Arch Pathol Lab Med. 2013 Apr;137(4):451. doi: 10.5858/arpa.2013-0951-ED.

The new american cancer society lung cancer screening guidelines and the role of the pathologist.

Cagle PT.

Source

From the Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, Texas; and the Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York.

"Pathologists will diagnose the increased number of aspirates, biopsies, and other procedures that will follow from LDCT screening. As pathologists are already aware, these tissues may need to be triaged for predictive biomarker testing or other studies, requiring conservation of tissue samples in many cases.3 This potential increase in testing takes place within the new context of cost containment and laboratory efficiency."